Literature DB >> 31537688

Unique clinico-biological, genetic and prognostic features of adult early T-cell precursor acute lymphoblastic leukemia.

Eulàlia Genescà1, Mireia Morgades2, Pau Montesinos3, Pere Barba4, Cristina Gil5, Ramon Guàrdia6, María-José Moreno7, Daniel Martínez-Carballeira8, Irene García-Cadenas9, Susana Vives2, Jordi Ribera10, José González-Campos11, Celia González-Gil10, Lurdes Zamora2, José-Luís Ramírez2, Marina Díaz-Beya12, Santiago Mercadal13, María-Teresa Artola14, Antònia Cladera15, Mar Tormo16, Arancha Bermúdez17, Ferran Vall-Llovera18, Pilar Martínez19, María-Luz Amigo20, Silvia Monsalvo21, Andrés Novo22, Marta Cervera23, Antoni García-Guiñon24, Jordi Juncà2, Juana Ciudad25, Alberto Orfao25, Josep-Maria Ribera10,2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31537688      PMCID： PMC7271589          DOI： 10.3324/haematol.2019.225078

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  17 in total

1.  Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trials.

Authors:  Pere Barba; Mireia Morgades; Pau Montesinos; Cristina Gil; María-Laura Fox; Juana Ciudad; María-José Moreno; José González-Campos; Eulàlia Genescà; Daniel Martínez-Carballeira; Rodrigo Martino; Susana Vives; Ramon Guardia; Santiago Mercadal; María-Teresa Artola; Antonia Cladera; Mar Tormo; Jordi Esteve; Juan Bergua; Ferran Vall-Llovera; Jordi Ribera; Pilar Martínez-Sanchez; María-Luz Amigo; Arantxa Bermúdez; María Calbacho; Jesús-Maria Hernández-Rivas; Evaristo Feliu; Alberto Orfao; Josep-María Ribera
Journal:  Eur J Haematol       Date:  2018-11-22       Impact factor: 2.997

2.  Early Response-Based Therapy Stratification Improves Survival in Adult Early Thymic Precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia Study.

Authors:  Jonathan Bond; Carlos Graux; Ludovic Lhermitte; Diane Lara; Thomas Cluzeau; Thibaut Leguay; Agata Cieslak; Amélie Trinquand; Cedric Pastoret; Mohamed Belhocine; Salvatore Spicuglia; Véronique Lheritier; Stéphane Leprêtre; Xavier Thomas; Françoise Huguet; Norbert Ifrah; Hervé Dombret; Elizabeth Macintyre; Nicolas Boissel; Vahid Asnafi
Journal:  J Clin Oncol       Date:  2017-06-12       Impact factor: 44.544

3.  Early T-cell precursor leukemia: a subtype of high risk childhood acute lymphoblastic leukemia.

Authors:  Meilin Ma; Xiang Wang; Jingyan Tang; Huiliang Xue; Jing Chen; Ci Pan; Hua Jiang; Shuhong Shen
Journal:  Front Med       Date:  2012-10-12       Impact factor: 4.592

4.  Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype.

Authors:  Nitin Jain; Audrey V Lamb; Susan O'Brien; Farhad Ravandi; Marina Konopleva; Elias Jabbour; Zhuang Zuo; Jeffrey Jorgensen; Pei Lin; Sherry Pierce; Deborah Thomas; Michael Rytting; Gautam Borthakur; Tapan Kadia; Jorge Cortes; Hagop M Kantarjian; Joseph D Khoury
Journal:  Blood       Date:  2016-01-08       Impact factor: 22.113

5.  Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia.

Authors:  Pieter Van Vlierberghe; Alberto Ambesi-Impiombato; Kim De Keersmaecker; Michael Hadler; Elisabeth Paietta; Martin S Tallman; Jacob M Rowe; Carles Forne; Montserrat Rue; Adolfo A Ferrando
Journal:  Blood       Date:  2013-05-17       Impact factor: 22.113

6.  Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors.

Authors:  Linda Zuurbier; Alejandro Gutierrez; Charles G Mullighan; Kirsten Canté-Barrett; A Olivier Gevaert; Johan de Rooi; Yunlei Li; Willem K Smits; Jessica G C A M Buijs-Gladdines; Edwin Sonneveld; A Thomas Look; Martin Horstmann; Rob Pieters; Jules P P Meijerink
Journal:  Haematologica       Date:  2013-08-23       Impact factor: 9.941

7.  Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia.

Authors:  Carmen Vicente; Claire Schwab; Michaël Broux; Ellen Geerdens; Sandrine Degryse; Sofie Demeyer; Idoya Lahortiga; Alannah Elliott; Lucy Chilton; Roberta La Starza; Cristina Mecucci; Peter Vandenberghe; Nicholas Goulden; Ajay Vora; Anthony V Moorman; Jean Soulier; Christine J Harrison; Emmanuelle Clappier; Jan Cools
Journal:  Haematologica       Date:  2015-07-23       Impact factor: 9.941

8.  Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations.

Authors:  M Neumann; S Heesch; N Gökbuget; S Schwartz; C Schlee; O Benlasfer; N Farhadi-Sartangi; J Thibaut; T Burmeister; D Hoelzer; W-K Hofmann; E Thiel; C D Baldus
Journal:  Blood Cancer J       Date:  2012-01-27       Impact factor: 11.037

9.  Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003.

Authors:  Katharine Patrick; Rachel Wade; Nick Goulden; Chris Mitchell; Anthony V Moorman; Clare Rowntree; Sarah Jenkinson; Rachael Hough; Ajay Vora
Journal:  Br J Haematol       Date:  2014-04-08       Impact factor: 6.998

10.  FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors.

Authors:  Martin Neumann; Ebru Coskun; Lars Fransecky; Liliana H Mochmann; Isabelle Bartram; Nasrin Farhadi Sartangi; Sandra Heesch; Nicola Gökbuget; Stefan Schwartz; Christian Brandts; Cornelia Schlee; Rainer Haas; Ulrich Dührsen; Martin Griesshammer; Hartmut Döhner; Gerhard Ehninger; Thomas Burmeister; Olga Blau; Eckhard Thiel; Dieter Hoelzer; Wolf-Karsten Hofmann; Claudia D Baldus
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240
View more
  7 in total

1.  In Silico Integration of Transcriptome and Interactome Predicts an ETP-ALL-Specific Transcriptional Footprint that Decodes its Developmental Propensity.

Authors:  Soumyadeep Mukherjee; Arpita Kar; Paramita Paul; Souvik Dey; Avik Biswas; Subhasis Barik
Journal:  Front Cell Dev Biol       Date:  2022-05-13

2.  Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma.

Authors:  Xinjie Xu; Christian N Paxton; Robert J Hayashi; Kimberly P Dunsmore; Stuart S Winter; Stephen P Hunger; Naomi J Winick; William L Carroll; Mignon L Loh; Meenakshi Devidas; Thomas G Gross; Catherine M Bollard; Sherrie L Perkins; Rodney R Miles
Journal:  Blood Adv       Date:  2021-07-27

Review 3.  The New Therapeutic Strategies in Pediatric T-Cell Acute Lymphoblastic Leukemia.

Authors:  Marta Weronika Lato; Anna Przysucha; Sylwia Grosman; Joanna Zawitkowska; Monika Lejman
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

4.  The evolution of relapse of adult T cell acute lymphoblastic leukemia.

Authors:  Inés Sentís; Santiago Gonzalez; Eulalia Genescà; Violeta García-Hernández; Ferran Muiños; Celia Gonzalez; Erika López-Arribillaga; Jessica Gonzalez; Lierni Fernandez-Ibarrondo; Loris Mularoni; Lluís Espinosa; Beatriz Bellosillo; Josep-Maria Ribera; Anna Bigas; Abel Gonzalez-Perez; Nuria Lopez-Bigas
Journal:  Genome Biol       Date:  2020-11-23       Impact factor: 13.583

Review 5.  Early T-Cell Precursor Acute Lymphoblastic Leukemia: Diagnosis, Updates in Molecular Pathogenesis, Management, and Novel Therapies.

Authors:  Chun-Fung Sin; Pui-Hei Marcus Man
Journal:  Front Oncol       Date:  2021-11-29       Impact factor: 6.244

Review 6.  Early T-Cell Precursor ALL and Beyond: Immature and Ambiguous Lineage T-ALL Subsets.

Authors:  Eulàlia Genescà; Roberta la Starza
Journal:  Cancers (Basel)       Date:  2022-04-08       Impact factor: 6.639

Review 7.  Early precursor T-cell acute lymphoblastic leukemia: current paradigms and evolving concepts.

Authors:  Omar Castaneda Puglianini; Nikolaos Papadantonakis
Journal:  Ther Adv Hematol       Date:  2020-07-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.